California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan.
The settlement in principle accounts for New Jersey-based Amneal's role in fueling the national epidemic of opioid addictions and overdoses, New York and California said in separate statements.
New Jersey-based drug manufacturer Amneal Pharmaceuticals has become the latest company to reach a settlement agreement with ...
U.S. pharmacy chain operator Walgreens Boots Alliance said on Wednesday it has launched its own brand of popular overdose ...
California Attorney General Rob Bonta on Friday announced a $273 million multistate settlement with New Jersey-based Amneal Pharmaceutical for the drug manufacturer's alleged failure to report ...
Walgreens is set to offer a cheaper version of an important opioid reversal drug at its stores soon, according to Wednesday ...
Narcan is a drug that can reverse the amount of opioids that are in a person’s system and has saved the lives of many people ...
The number of U.S. fatal overdoses fell last year. The Centers for Disease Control and Prevention posted the numbers ...
New York state will get a cut of a $270 million multistate settlement with opioid maker Amneal Pharmaceuticals over ...
SACRAMENTO, Calif. — California will soon begin selling its own generic version of Narcan — the drug that can save someone’s life during an opioid overdose — under a deal announced Monday ...
California settled an opioid lawsuit against Amneal Pharmaceuticals in the same week that it struck a contract to buy discount overdose medication from the company.
California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan SACRAMENTO, Calif. -- California will soon begin selling its own generic version of ...